Partnerships and Strategic Initiatives

For the Canadian Agency for Drugs and Technologies in Health (CADTH), collaboration is essential to meet the growing demand for reliable information and advice on drugs and other health technologies in Canada, and to support the success of our program areas. Through partnerships and strategic initiatives, we aim to build new capacity to produce and use evidence-based information in Canada.

By working cooperatively with like-minded agencies and organizations across the country and around the world, we strive to support decision-making processes as effectively and efficiently as possible. Cooperation allows our partners and us to achieve otherwise unattainable goals.

Our partnership activities centre on sharing information, learning from others, and increasing coordination and cooperation. In Canada, we are committed to building on existing networks and the significant investments in research, assessment, and appraisal that have already been made across the country.

CADTH partners with more than 50 organizations across Canada and more than 15 organizations worldwide as we look for the most effective means to achieve our mandate.

Strategic Partnership Initiatives

Consultations

In association with other national organizations, CADTH participates in regular national consultations designed to identity health policy and research priorities.

Symposia

CADTH organizes an annual symposium that brings together Canada’s leading producers and users of evidence-based information on drugs and other health technologies for informative and timely discussions about how to integrate evidence into health care decisions more effectively.

Funding Agreements

We work with key partners to secure funding for projects and initiatives of benefit to Canada’s health policy decision makers. Our agreements have included:

  • a three-year funding agreement with the Canadian Institutes of Health Research and the Heart and Stroke Foundation of Canada to support the development of new tools and other resources to help policymakers deal with the rapid growth of genetic technologies
  • a six-year multi-partner agreement to provide stable funding to the Cochrane Collaboration in Canada, thereby enhancing Canada's reputation as a leader in health research.

Some of our Canadian partners

Some of our international partners